COVID-19 and the fear of stepping out forces patients to adopt at-home therapies The looming threat and fear of coronavirus has pushed people back inside their homes. The year 2020 showed us limitations in the healthcare infrastructure, unable to support critical healthcare issues. The lockdown affected
There is a need for awareness around the health complications of atherosclerosis and the importance of managing vitals There is a rise in the incidence and prevalence of atherosclerotic diseases such as coronary heart disease, stroke, etc. Both men and women are susceptible to this condition
The chances of people developing mucormycosis (black fungus) post taking the vaccine are lower With herd immunity, the severity of 3rd wave will be less severe than 2nd wave Delta plus variant remains the cause of concern Antibodies produced by the vaccine protect against
Apollo Hospitals begins offering the Antibody Cocktail (Casirivimab and Imdevimab) to patients with mild and moderate COVID and at high risk of developing severe COVID Indraprastha Apollo Hospitals, Delhi today announced that Roche India’s Antibody Cocktail (Casirivimab and Imdevimab) distributed by Cipla Ltd. is available for
